Tetrahydrofuran

Tetrahydrofuran

SCHEMBL15375263

C1CCOC1.C1CO1.C1CO1.CC1CO1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
TTR P02766 1/20 0.38
CHRM2 P08172 3/20 0.30
CHRM5 P08912 3/20 0.30
CHRM3 P20309 3/20 0.30
CHRM4 P08173 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL893856 1.00 ALDH1A1 (0.50) ALDH1A1TTRCHRM2CHRM5CHRM3
Tetrahydrofuran SCHEMBL209705 0.97
Propylene Oxide SCHEMBL5703388 0.94 ALDH1A1 (0.50) ALDH1A1CHRM2CHRM5CHRM3CHRM4
Propylene Oxide SCHEMBL27902062 0.94 ALDH1A1 (0.50) ALDH1A1CHRM2CHRM5CHRM3CHRM4
Propylene Oxide SCHEMBL5703236 0.94 ALDH1A1 (0.50) ALDH1A1CHRM2CHRM5CHRM3CHRM4
Tetrahydrofuran SCHEMBL7167854 0.87 ALDH1A1 (0.38) ALDH1A1
Propylene Oxide SCHEMBL10532443 0.87 TSHR (0.43) TTRCHRM2CHRM5CHRM3CHRM4
Propylene Oxide SCHEMBL2992333 0.87 TTR (0.39) TTRCHRM2CHRM5CHRM3CHRM4
Propylene Oxide SCHEMBL5157871 0.87 TTR (0.39) TTRCHRM2CHRM5CHRM3CHRM4
Propylene Oxide SCHEMBL19252817 0.87 TTR (0.39) TTRCHRM2CHRM5CHRM3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2662400-B1 Block type-modified organopolysiloxane, method for using the organopolysiloxane, cosmetic, and method for producing the organopolysiloxane SHINETSU CHEMICAL CO (JP) 2017-09-13 EP disclosed
US-9078836-B2 Block type-modified organopolysiloxane, method for using the organopolysiloxane, cosmetic, and method for producing the organopolysiloxane SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-07-14 US disclosed
US-20130302263-A1 BLOCK TYPE-MODIFIED ORGANOPOLYSILOXANE, METHOD FOR USING THE ORGANOPOLYSILOXANE, COSMETIC, AND METHOD FOR PRODUCING THE ORGANOPOLYSILOXANE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-14 US disclosed
EP-2662400-A2 Block type-modified organopolysiloxane, method for using the organopolysiloxane, cosmetic, and method for producing the organopolysiloxane Shin-Etsu Chemical Co., Ltd. (JP) 2013-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130302263-A1 BLOCK TYPE-MODIFIED ORGANOPOLYSILOXANE, METHOD FOR USING THE ORGANOPOLYSILOXANE, COSMETIC, AND METHOD FOR PRODUCING THE ORGANOPOLYSILOXANE H1-0, H1-4, H1-2 ALDH1A1 1806/4885TTR 1058/4885CHRM2 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.